New biomarkers for RCC subtypes improving diagnosis & treatmentbiomarkers| Clinical Trials| diagnosis| geonomics| renal cell carcinoma| study| tumorsMassive study identifies new biomarkers for renal cancer subtypes, improving diagnosis ...
Pharma’s partner for phase Ib of RCC trialbelzutifan| Clinical Trials| HC-7366| HiberCell| merckMerck partners with HiberCell for Phase Ib renal carcinoma trial The Phase Ib trial will evaluate the ...
Clinical Trial News – PEAR-TREE 2Clinical Trials| ResearchExploring how to match treatments to patients Patients with advanced or metastatic kidney cancer now have a range ...
National Cancer Research Institute (NCRI) to closeClinical Trials| kidney cancer| NCRI| Rob Jones| The National Cancer Research InstituteThe National Cancer Research Institute (NCRI) has announced that it will be winding down its operations prior to ...
ALLO-316 Demonstrates Antitumor Activity in Advanced ccRCCALLO-316| car t| Clinical TrialsData Provide Proof-of-Concept for an Allogeneic Anti-CD70 CAR T Candidate in Patients with Renal Cell Carcinoma ...